Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1034 | 1008 | 1040 | 1077 | 1524 | 2501 |
Fund Return | 3.37% | 0.82% | 4% | 2.49% | 8.79% | 9.6% |
Place in category | 365 | 455 | 358 | 213 | 46 | 8 |
% in Category | 70 | 90 | 81 | 51 | 11 | 3 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DNCA Invest Eurose Class I shares E | 2.45B | 1.78 | 3.84 | 2.75 | ||
DNCA Invest Eurose Class AD shares | 2.45B | 1.54 | 3.10 | 2.01 | ||
DNCA Invest Eurose Class A shares | 2.45B | 1.54 | 3.10 | 2.01 | ||
DNCA Invest Europe Growth Class A s | 1.24B | 2.95 | 1.30 | 8.46 | ||
DNCA Invest Europe Growth Class B s | 1.24B | 2.81 | 0.92 | 8.07 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DNCA Invest Europe Growth Class A s | 1.24B | 2.95 | 1.30 | 8.46 | ||
DNCA Invest Europe Growth Class B s | 1.24B | 2.81 | 0.92 | 8.07 | ||
DNCA Invest Europe Growth Class I s | 1.24B | 3.30 | 2.30 | 9.46 | ||
LU1330191385 | 1.02B | 5.17 | 12.41 | - | ||
BlackRock European Opp Extension X2 | 730.49M | 6.08 | 9.22 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 9.93 | 928.8 | -0.92% | |
ASML Holding | NL0010273215 | 6.50 | 880.50 | +0.47% | |
Edenred | FR0010908533 | 4.73 | 44.86 | -1.54% | |
AstraZeneca | GB0009895292 | 4.40 | 12,296.0 | -0.87% | |
Schneider Electric | FR0000121972 | 4.39 | 238.20 | +1.04% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review